Indication

For the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).

Medicine details

Medicine name:
avatrombopag (Doptelet)
SMC ID:
SMC2345
Pharmaceutical company
Swedish Orphan
BNF chapter
Nutrition and blood
Submission type
Full
Publication due date:
09 August 2021
SMC meeting date:
06 July 2021
Patient group submission deadline:
31 May 2021